3Schapira AH.Etiology of Parkinson's disease[J].Neurology,2006,66(10 Suppl 4):S10-S23.
4Barnham KJ,Masters CL,Bush AI.Neurodegenerative diseases and oxidative stress[J].Nat Rev Drug Discov,2004,3:205-214.
5Arai H,Furuya T,Mizuno Y,et al.Inflammation and infection in Parkinson's disease[J].Histol Histopathol,2006,21:673-678.
6Ghezzi P,Brines M.Erythropoietin as an anti-apoptotic,tissue-neuroproctive cytokine[J].Cell Death Diff,2004,11(Suppl):S37-S44.
7Viviani B,Bartesaghi S,Corsini E.Erythropoietin protects primary hippocampal neurons increasing the expression of brian-derived neurotrophic factor[J].Neurochem,2005,93:412-421.
8Um M,Lodish HF.Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathwaws[J].Biol Chem,2006,282(9):5648-5656.
9Kilic E,Kilic U,Soliz J,et al.Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways[J].FASEB J,2005,19(14):2026-2028.
10Zhao W,Kitidis C,Fleming MD,et al.Erythropoietin stimulates phosphsrylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway[J].Blood,2006,107(3):907-915.
二级参考文献7
1[1]Juul SE,Anderson DK,Li Y,et al.Erythropoietin and erythropoietin receptor in the developing human central nervous system[J].Pediatr Res,1998,43 (1):40.
2[3]Rink A,Fung KM,Trojanowski JQ,et al.Evidence of apoptotic cell death after experimental traumatic brain injury in the rat[J].Am J Path,1995,147(6):1575.
3[4]Brines M,Ghezzi P,Keenan S,et al.Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury[J].Proc Natl Acad Sci USA,2000,97:10526.
4[5]Chen C,Sytkowski AJ.Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of cmyc[J].J Biol Chem,2001,276(42):38518.
5[6]Digicaylioglu M,Lipton SA.Erythropoietin mediated neuro-protection involves cross-talk between Jak2 and NF2 kappa B signaling cascades[J].Nature,2001,412(6847):641.
6[7]Chong ZZ,Lin SH,Kang JQ,et al.Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1,3 and 8[J].J Neuroscience Res,2003,71(5):659.
6JACOBSON LO, GOLDWASSER E, FRIED W, et al. Role of the kidney in erythropoiesis [J]. Nature,1957,179:633-634.
7Bernaudin M, Marti HH, Roussel S, et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice [J]. J Cereb Blood Flow Metab,1999,19:643-651.
8Ehrenreich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial [J]. Mol Med, 2002,8:495-505.
9Ehrenreich H, Fischer B, Norra C, et al. Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis [J]. Brain,2007,130:2577-2588.
10Ganser C, Papazoglou A, Just L, et al. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencepha- lic dopamine-rich cultures [J]. Exp Cell Res,2010,316:737-746.
